← Back to Search

Behavioural Intervention

Atomic App for Pediatric Cancer Survivors

N/A
Recruiting
Led By Olga H Toro-Salazar
Research Sponsored by Connecticut Children's Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial tested an app to increase exercise in childhood cancer survivors, to improve their health. #physicalactivity #childhoodcancer

Who is the study for?
This trial is for childhood cancer survivors aged 10 to 30 who can speak English fluently. They must have been treated with anthracycline therapy. It's not suitable for those unable to cooperate in interviews, non-English speakers, or anyone unable to understand interview content.
What is being tested?
The ATOMIC mobile app is being tested for its ability to increase physical activity levels among children and young adults who survived pediatric cancer. The study involves development and usability testing of the app specifically designed for this group.
What are the potential side effects?
Since this trial tests a mobile app designed to encourage physical activity, there are no direct medical side effects like you'd expect from medication. However, participants may experience fatigue or muscle soreness typical with new exercise routines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ease of use and user errors will be documented for each individual during usability testing, by completing several tasks while navigating the mobile app platform
The Acceptability E-Scale is six-item tool that has been validated for assessing the usability, acceptability, and satisfaction of web based programs with statements ranked on a five point scale from very difficult to very easy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Real life usability testingExperimental Treatment1 Intervention
B) "Real Life" Usability Testing. We will conduct a "real life" usability test in a sample of 6 pediatric cancer survivors. EX@HOME: Patients will perform an individualized aerobic and resistance exercise intervention, choosing from a list of PA, progressing from light to moderate-to-vigorous intensity totaling 30-45 min/d, 4-5 weekly/wk. for 4 weeks. The social-cognitive-theory-based mobile app will support the exercise intervention. One-on-one messaging chats with a PA coach through the mobile app will facilitate exercise goal establishment and attainment.

Find a Location

Who is running the clinical trial?

Connecticut Children's Medical CenterLead Sponsor
73 Previous Clinical Trials
26,560 Total Patients Enrolled
The Hospital for Sick ChildrenOTHER
712 Previous Clinical Trials
6,959,703 Total Patients Enrolled
Olga H Toro-SalazarPrincipal InvestigatorCT Children's Medical Center

Media Library

ATOMIC (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05792566 — N/A
Pediatric Cancer Research Study Groups: Real life usability testing
Pediatric Cancer Clinical Trial 2023: ATOMIC Highlights & Side Effects. Trial Name: NCT05792566 — N/A
ATOMIC (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05792566 — N/A
~0 spots leftby Dec 2024